Ultra-High Frequency UltraSound (UHFUS) Assessment of Barrier Function in Moderate-to-Severe Atopic Dermatitis during Dupilumab Treatment

Ultra-High Frequency UltraSound (UHFUS) Assessment of Barrier Function in Moderate-to-Severe Atopic Dermatitis during Dupilumab Treatment

Atopic dermatitis (AD) is a chronic multifactorial inflammatory disease characterized by intense itching and inflammatory eczematous lesions. Biological disease-modifying drugs, such as dupilumab are recommended for patients with moderate-to-severe AD, refractory to systemic immunosuppressive therap...

Full description

Bibliographic Details
Main Authors: Valentina Dini, Michela Iannone, Alessandra Michelucci, Flavia Manzo Margiotta, Giammarco Granieri, Giorgia Salvia, Teresa Oranges, Agata Janowska, Riccardo Morganti, Marco Romanelli
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Diagnostics
Subjects:
atopic dermatitis
ultra-high frequency ultrasound
SLEB
dupilumab
corneometry
Online Access:https://www.mdpi.com/2075-4418/13/17/2721

Internet

https://www.mdpi.com/2075-4418/13/17/2721

Similar Items